Cargando…
Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
Autores principales: | Soria, Francesco, Shariat, Shahrokh F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323279/ https://www.ncbi.nlm.nih.gov/pubmed/30687617 http://dx.doi.org/10.21037/tau.2018.08.10 |
Ejemplares similares
-
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018) -
Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019) -
Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses?
por: Rink, Michael, et al.
Publicado: (2016) -
Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery
por: Abufaraj, Mohammad, et al.
Publicado: (2016) -
Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020)